These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9784141)

  • 1. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
    Prix L; Maierl J; Jahn G; Hamprecht K
    J Clin Virol; 1998 Jul; 11(1):29-37. PubMed ID: 9784141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
    Sarasini A; Baldanti F; Furione M; Percivalle E; Brerra R; Barbi M; Gerna G
    J Med Virol; 1995 Nov; 47(3):237-44. PubMed ID: 8551275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
    Eckle T; Jahn G; Hamprecht K
    J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.
    Gerna G; Sarasini A; Percivalle E; Zavattoni M; Baldanti F; Revello MG
    J Clin Microbiol; 1995 Mar; 33(3):738-41. PubMed ID: 7751388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
    Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.
    Schnepf N; Boiteau N; Petit F; Alain S; Sanson-Le Pors MJ; Mazeron MC
    Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
    Baldanti F; Revello MG; Percivalle E; Gerna G
    J Clin Virol; 1998 Jul; 11(1):51-60. PubMed ID: 9784143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood.
    Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G
    Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.
    Baldanti F; Sarasini A; Drach JC; Zemlicka J; Gerna G
    Antiviral Res; 2002 Dec; 56(3):273-8. PubMed ID: 12406510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.
    Landry ML; Stanat S; Biron K; Brambilla D; Britt W; Jokela J; Chou S; Drew WL; Erice A; Gilliam B; Lurain N; Manischewitz J; Miner R; Nokta M; Reichelderfer P; Spector S; Weinberg A; Yen-Lieberman B; Crumpacker C
    Antimicrob Agents Chemother; 2000 Mar; 44(3):688-92. PubMed ID: 10681339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay.
    Gerna G; Baldanti F; Zavattoni M; Sarasini A; Percivalle E; Revello MG
    Antiviral Res; 1992 Oct; 19(4):333-45. PubMed ID: 1334396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance.
    Lipson SM; Soni M; Biondo FX; Shepp DH; Kaplan MH; Sun T
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):123-9. PubMed ID: 9294702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.
    Tatarowicz WA; Lurain NS; Thompson KD
    J Infect Dis; 1992 Oct; 166(4):904-7. PubMed ID: 1326585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Pérez JL
    Microbiologia; 1997 Sep; 13(3):343-52. PubMed ID: 9353754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
    Dunn JP; MacCumber MW; Forman MS; Charache P; Apuzzo L; Jabs DA
    Am J Ophthalmol; 1995 May; 119(5):587-96. PubMed ID: 7733184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates.
    McSharry JM; Lurain NS; Drusano GL; Landay A; Manischewitz J; Nokta M; O'Gorman M; Shapiro HM; Weinberg A; Reichelderfer P; Crumpacker C
    J Clin Microbiol; 1998 Apr; 36(4):958-64. PubMed ID: 9542916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strains of ganciclovir-resistant cytomegalovirus].
    Calicó I; García E; Cortés A; Gavaldá J; Roman A; Valle I
    Enferm Infecc Microbiol Clin; 1999; 17(7):330-4. PubMed ID: 10535184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.